DTRA Awards NanoBiosym $2M Contract to Develop Genomics/Nanotech Dx for Biodefense | GenomeWeb
NEW YORK (GenomeWeb News) - Nanobiosym, a Massachusetts company that is developing a diagnostic tool that blends nanotechnology and genomics, said on Friday that it has received a $2 million contract from the United States Defense Threat Reduction Agency.
 
The company plans to use the contract to validate the use of its technology, called Gene-RADAR, which it has been developing with its commercial partner, Nanobiosym Diagnostics.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.